When investing in biotech, you must take a leap of faith, says Cytokinetics’ Chairman and Co-founder James Sabry. When working in the realm of raw science, there is no guarantee that an avenue of exploration will necessarily lead toward fruitful results. Anyone embarking upon this sect of start-up must be prepared for every possible outcome.